Latest filing published 31 Aug 2023 for IDEAYA Biosciences, Inc., €133k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul A. Stone: trading record in brief
Paul A. Stone (finance chief) discloses dealings in IDEAYA Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 28 May 2019 to 29 August 2023, the count stands at 21 filings.
On the open market, the record shows 2 purchases worth €2.2M and 9 sales worth €419k. The net balance comes to €1.8M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 4 option exercises. So far in 2023, the count stands at no purchases and 6 sales.
The record was last updated on 31 August 2023 with an open-market sale (€133k) in IDEAYA Biosciences, Inc. The most recent open-market purchase was published on 28 May 2019, 2,722 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul A. Stone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$28.870342.1% of flowCommon StockSEC:0001610717-23-000251:0
- 978 shares@ US$26.40037.5% of flowCommon StockSEC:0001610717-23-000234:0
- 100 shares@ US$26.400.1% of flowCommon StockSEC:0001610717-23-000233:1
- 3,822 shares@ US$26.383.3% of flowCommon StockSEC:0001610717-23-000233:2
- 100 shares@ US$26.450.8% of flowCommon StockSEC:0001610717-23-000233:0
- 2,500 shares@ US$25.045318.1% of flowCommon StockSEC:0001610717-23-000225:0
- 8,000 shares@ US$4.6210.6% of flowCommon StockSEC:0001610717-23-000009:0
- 859 shares@ US$11.36452.5% of flowCommon StockSEC:0001567619-22-008545:0
- 2,500 shares@ US$27.41718.4% of flowCommon StockSEC:0001567619-21-016924:0
- 444 shares0Common StockSEC:0001567619-20-021089:0
- 3,100 shares@ US$4.623.2% of flowCommon StockSEC:0001567619-20-012462:0
- 2,500 shares@ US$17.509.8% of flowCommon StockSEC:0001567619-20-012462:1
- 600 shares@ US$19.952.7% of flowCommon StockSEC:0001567619-20-012462:2
- 5,000 shares@ US$4.624.8% of flowCommon StockSEC:0001567619-20-007287:0
- 10,000 shares@ US$4.621.5% of flowCommon StockSEC:0001567619-19-015342:0
- 1,721,898 sharesCommon StockSEC:0001567619-19-012281:0
- 578,447 sharesCommon StockSEC:0001567619-19-012281:1
- 71,745 sharesCommon StockSEC:0001567619-19-012281:2
- 24,101 sharesCommon StockSEC:0001567619-19-012281:3
- 240,000 shares@ US$10.0080.2% of flowCommon StockSEC:0001567619-19-012281:4Canonical exit: 26 Aug 2019 (T+90)
- 10,000 shares@ US$10.003.3% of flowCommon StockSEC:0001567619-19-012281:5Canonical exit: 26 Aug 2019 (T+90)
21 of 19 declarations
